StephanJosephDorkhomDO

PubMed

• 58 citations
  Hepatocellular carcinoma in two patients with cardiac cirrhosis.
  Teddy Saliba, Stephan Dorkhom, Eileen M. O'Reilly, Emmy Ludwig, Bolorsukh Gansukh, Ghassan K. Abou-Alfa> ;European Journal of Gastroenterology & Hepatology. 2010 Jul 1
• 31 citations
  Novel Kelch-like Protein, KLEIP, Is Involved in Actin Assembly at Cell-Cell Contact Sites of Madin-Darby Canine Kidney Cells
  Takahiko Hara, Hiroshi Ishida, Razi Raziuddin, Stephan Dorkhom, Keiju Kamijo, Toru Miki> ;Molecular Biology of the Cell. 2003 Dec 10

Books/Book Chapters

• Advances in the Treatment of Chronic Myeloid Leukemia 
  Chapter: Treatment options for tyrosine kinase inhibitor-resistant chronic myeloid leukemia 
  Page 78 - 96Stephan Joseph Dorkhom, Hady Ghanem, and Elias JabbourUnitec House (Future Medicine Ltd), London N3 1QB, United Kingdom2013

Abstracts/Posters

• Interim Analysis of a Phase II Study of the c-Met Inhibitor ARQ 197 (Tivantinib) in Patients with Relapsed Multiple Myeloma.
  Dorkhom, SJ, Thomas SK, Alexanian R, Shah J, Webber DM, Wang M, Anderson ML, Morales de Partovie C, Ghandi VV, Orlowski RZ, American Society of Hematology National Meeting, The University of Texas MD Anderson Cancer Center, 12/2012
• Interim results of a phase I/II randomized study of clofarabine, idarubicin, and cytarabine (CIA) versus fludarabine, idarubicin, and cytarabine (FIA) for newly diagno...
  Mathisen M, Kantarjian H, Faderl S, Garcia-Manero G, Ravandi F, Kadia TM, Daver NG, O'Brien SM, Dorkhom SJ, Pierce S, Lira C, Cortes JE, Jabbour E, American Society of Clinical Oncology National Meeting, The University of Texas MD Anderson Cancer Center, 6/2012
• Allogenic stem cell transplant (ASCT) as initial salvage for patients with acute myeloid leukemia (AML) refractory to high-dose cytarabine-based induction chemotherapy
  Daver NG, De Lima M JG, Kantarjian H, Ravandi F, Asim Bilen M, Pierce S, Khouri IF, Dorkhom SJ, Giralt S, Garcia-Manero G, Nazha A, Mathisen M, Pemmaraju N, Cortes JE,..., American Society of Clinical Oncology National Meeting, The University of Texas MD Anderson Cancer Center, 6/2012
• BRAF, NRAS, and KIT mutational analysis in spindle cell melanoma
  Dorkhom SJ, Kim J, Lazar AJ F, Davies MA, Homsi J, Papadopoulos NE, Hwu W, Bedikian AY, Woodman SE, Patel SP, Hwu P, Kim KB, American Society of Clinical Oncology National Meeting, The University of Texas MD Anderson Cancer Center, 6/2011
• Join now to see all